CN107233393A - A kind of pharmaceutical composition for treating gout - Google Patents
A kind of pharmaceutical composition for treating gout Download PDFInfo
- Publication number
- CN107233393A CN107233393A CN201710301253.6A CN201710301253A CN107233393A CN 107233393 A CN107233393 A CN 107233393A CN 201710301253 A CN201710301253 A CN 201710301253A CN 107233393 A CN107233393 A CN 107233393A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- gout
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of pharmaceutical composition for treating gout, the Chinese medicine matched by following parts by weight is constituted：10 ~ 30 parts of radix semiaquilegiae, 15 ~ 25 parts of Sargent gloryvine, 20 ~ 40 parts of Canton love-pea vine, 20 ~ 30 parts of the root of bidentate achyranthes, 20 ~ 40 parts of plantain seed.Present invention treatment gout effect is good, and clinical test is proved, with obvious therapeutic effect.
Description
Technical field
The present invention relates to pharmaceutical composition, and in particular to a kind of pharmaceutical composition for treating gout.
Background technology
Gout is by monosodium urate salt（MSU）Deposition caused by crystal correlation arthropathy, with purine metabolic disturbance and
（Or）Hyperuricemia caused by underexcretion is directly related, refers in particular to acute characteristic arthritis and chronic gout stone disease
Disease, mainly includes acute attack arthritis, tophus formation, tophaceous chornic arthritis, urate nephropathy and uric acid
Lithangiuria, severe one may occur in which joint deformity and renal insufficiency.
In recent years, number of patients substantially increased.At present to this sick treatment still based on Western medicine, conventional has colchicum
Alkali, allopurinol, foregoing medicine, mostly abirritant, it is difficult to effect a radical cure, and all with obvious toxic side effect, such as stomach and intestine not
Hemorrhagic enteritis can occur for suitable, severe patient, and blood middle leukocytes are reduced, severe patient can cause aplastic anemia, alopecia, flesh
Disease, hepatic disorder, depression etc..Before this, there are 25-component sophora flower ball, vast stretch of wooded country chinkuning for treating the Chinese medicine of gout
Etc. a small amount of patent medicine, but cure rate is not also high, and part sufferer curative effect is not obvious.
The content of the invention
To overcome existing technological deficiency, the invention provides a kind of medicine of the treatment gout good for goat curative effect
Composition.
To realize the purpose of the present invention, it is achieved using following technical scheme：
A kind of pharmaceutical composition for treating gout, the Chinese medicine matched by following parts by weight is constituted：10 ~ 30 parts of radix semiaquilegiae is red
15 ~ 25 parts of rattan, 20 ~ 40 parts of Canton love-pea vine, 20 ~ 30 parts of the root of bidentate achyranthes, 20 ~ 40 parts of plantain seed.
Radix semiaquilegiae is sweet, hardship, cold in nature, Return liver, stomach, with clearing heat and detoxicating, the effect of dispersing swelling and dissipating binds.Sargent gloryvine is Lardizabalaceae
The rattan of plant sargentodoxa cuneata, bitter is mild-natured, returns large intestine, Liver Channel, has removing toxicity for eliminating carbuncles, promoting blood circulation and stopping pain, dispelling wind and eliminating dampness, disinsection efficiency.
Canton love-pea vine is sweet, slight bitter, cool, there is removing dampness through diuresis and removing jaundice, clearing heat and detoxicating, the effect of dispersing the depressed liver-qi and alleviating pain.Root of bidentate achyranthes bitter, sweet, acid, put down, Return liver,
Kidney channel, with dispelling stasis of blood and stimulating the menstrual flow, filling liver kidney, strengthening the bones and muscles, inducing diuresis for treating strangurtia, the effect ensuringd proper downward flow of the blood.Plantain seed is sweet in flavor and cold in property, enter kidney,
Bladder, liver, lung channel, function promoting diuresis for stranguria, excreting dampness antidiarrheal, clear liver and improve vision, clearing heat and eliminating phlegm.Pharmaceutical formulation of the present invention is scientific and reasonable,
Acted synergistically between each component, can promoting blood circulation and removing obstruction in channels, regulating qi-flowing for relieving pain, righting method heresy, regulation internal system, to gout with preferable
Therapeutic effect.
Further, the Chinese medicine that aforementioned pharmaceutical compositions are matched by following parts by weight is constituted：15 ~ 25 parts of radix semiaquilegiae,
18 ~ 22 parts of Sargent gloryvine, 25 ~ 30 parts of Canton love-pea vine, 22 ~ 28 parts of the root of bidentate achyranthes, 25 ~ 35 parts of plantain seed.
Further, the Chinese medicine that aforementioned pharmaceutical compositions are matched by following parts by weight is constituted：20 parts of radix semiaquilegiae, Sargent gloryvine
20 parts, 26 parts of Canton love-pea vine, 24 parts of the root of bidentate achyranthes, 30 parts of plantain seed.
Compared with the prior art, present invention treatment gout effect is good, and clinical test is proved, with obvious therapeutic effect.
Embodiment
To make the object, technical solutions and advantages of the present invention clearer, further is made to embodiment of the present invention below
Explain.
Embodiment 1
A kind of pharmaceutical composition for treating gout, the Chinese medicine matched by following parts by weight is constituted：10 parts of radix semiaquilegiae, Sargent gloryvine 15
Part, 20 parts of Canton love-pea vine, 20 parts of the root of bidentate achyranthes, 20 parts of plantain seed.
Each group in this formula is divided into 1 dose of dose, to be decocted in water for oral dose, daily 1 dose, is taken for 2 times per natural gift.
Embodiment 2
A kind of pharmaceutical composition for treating gout, the Chinese medicine matched by following parts by weight is constituted：30 parts of radix semiaquilegiae, Sargent gloryvine 25
Part, 40 parts of Canton love-pea vine, 30 parts of the root of bidentate achyranthes, 40 parts of plantain seed.
Each group in this formula is divided into 1 dose of dose, to be decocted in water for oral dose, daily 1 dose, is taken for 2 times per natural gift.
Embodiment 3
A kind of pharmaceutical composition for treating gout, the Chinese medicine matched by following parts by weight is constituted：20 parts of radix semiaquilegiae, Sargent gloryvine 20
Part, 26 parts of Canton love-pea vine, 24 parts of the root of bidentate achyranthes, 30 parts of plantain seed.
Each group in this formula is divided into 1 dose of dose, to be decocted in water for oral dose, daily 1 dose, is taken for 2 times per natural gift.
Embodiment 4
Summarized using the clinical efficacy of embodiment 1：
First, clinical data：100 patient with gout of clinical treatment, patient checks through joint x ray photograph, blood uric acid, urine uric acid etc.
Make a definite diagnosis.
2nd, treatment method：Each group in this formula is divided into 1 dose of dose, to be decocted in water for oral dose, daily 1 dose, per 2 clothes of natural gift
With, continuously take one month observation curative effect.
3rd, therapeutic evaluation：
Cure：Symptom disappears, laboratory examination is normal.
Take a turn for the better：Arthroncus is disappeared, and pain relief, laboratory examination makes moderate progress.
It is invalid：Symptom and laboratory examination are unchanged.
4th, therapeutic effect：Using present invention treatment 100,74 are as a result cured, is taken a turn for the better 20, invalid 6.
5th, model case
1. case 1, Mr. Wang, man, 45 years old, toe, ankle-joint, knee joint were red and swollen, heat pain, knee articulation inconvenience, blood urine
432 μm of ol/L of acid, are diagnosed as goat.After drug therapy made from embodiment 1 one month, symptom mitigation is controlled after two months
More, follow-up 2 years is without recurrence.
2. case 2, Zhang, female, 52 years old, wrist joint, elbow joint were red and swollen, heat pain, exercising elbow joint inconvenience, blood uric acid
245 μm of ol/L, are diagnosed as goat.After drug therapy made from embodiment 1 one month, symptom mitigation is controlled after two months
More, freely, follow-up 2 years is without recurrence for wrist joint and exercising elbow joint.
3. case 3, Zhang, man, 61 years old, the swelling of left foot toe, stiff, pain, 371 μm of ol/L of blood uric acid were diagnosed as
Goat.After drug therapy made from embodiment 1 one month, symptom mitigation is cured after two months, wrist joint and elbow joint
Freely, follow-up 2 years is without recurrence for activity.
Embodiment 5
Summarized using the clinical efficacy of embodiment 2：Patient on medication's formula is the formula of embodiment 2, and other are constant.
Therapeutic effect：Using present invention treatment 100,76 are as a result cured, is taken a turn for the better 19, invalid 5.
Embodiment 6
Summarized using the clinical efficacy of embodiment 3：Patient on medication's formula is the formula of embodiment 3, and other are constant.
Therapeutic effect：Using present invention treatment 100,80 are as a result cured, is taken a turn for the better 17, invalid 3.
Claims (3)
1. a kind of pharmaceutical composition for treating gout, it is characterised in that the Chinese medicine matched by following parts by weight is constituted：Semiaquilegia adoxoides
10 ~ 30 parts of son, 15 ~ 25 parts of Sargent gloryvine, 20 ~ 40 parts of Canton love-pea vine, 20 ~ 30 parts of the root of bidentate achyranthes, 20 ~ 40 parts of plantain seed.
2. the pharmaceutical composition for the treatment of gout according to claim 1, it is characterised in that matched by following parts by weight
Chinese medicine is constituted：15 ~ 25 parts of radix semiaquilegiae, 18 ~ 22 parts of Sargent gloryvine, 25 ~ 30 parts of Canton love-pea vine, 22 ~ 28 parts of the root of bidentate achyranthes, 25 ~ 35 parts of plantain seed.
3. the pharmaceutical composition for the treatment of gout according to claim 2, it is characterised in that matched by following parts by weight
Chinese medicine is constituted：20 parts of radix semiaquilegiae, 20 parts of Sargent gloryvine, 26 parts of Canton love-pea vine, 24 parts of the root of bidentate achyranthes, 30 parts of plantain seed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710301253.6A CN107233393A (en) | 2017-05-02 | 2017-05-02 | A kind of pharmaceutical composition for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710301253.6A CN107233393A (en) | 2017-05-02 | 2017-05-02 | A kind of pharmaceutical composition for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107233393A true CN107233393A (en) | 2017-10-10 |
Family
ID=59984303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710301253.6A Withdrawn CN107233393A (en) | 2017-05-02 | 2017-05-02 | A kind of pharmaceutical composition for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107233393A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107929601A (en) * | 2017-12-25 | 2018-04-20 | 广西壮要方医院有限公司 | A kind of medicine for treating gout |
-
2017
- 2017-05-02 CN CN201710301253.6A patent/CN107233393A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107929601A (en) * | 2017-12-25 | 2018-04-20 | 广西壮要方医院有限公司 | A kind of medicine for treating gout |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441081A (en) | Medicament for treating gout and its preparation method | |
| CN102526611B (en) | Chinese medicinal composition for treating chronic heart failure | |
| CN106511510A (en) | Medicine composition used for treating wind-cold-damp arthralgia and muscle and bone strain | |
| CN104667035A (en) | Medicament for treating gout | |
| CN107233393A (en) | A kind of pharmaceutical composition for treating gout | |
| CN102670914A (en) | Chinese medicine oral fluid with bupleurum for curing chronic gastroenteritis and preparing method thereof | |
| CN103830325A (en) | Traditional Chinese medicine fumigant and nursing method for treating knee osteoarthritis | |
| CN101829248B (en) | Traditional Chinese medicine for treating goiter | |
| CN100490865C (en) | Kidney-nourishing gout-treating capsule | |
| CN103599321B (en) | Traditional Chinese medicine composition for treating osteoporosis | |
| CN106362066A (en) | Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof | |
| CN106975036A (en) | A kind of compound deacidification tea and preparation method thereof | |
| CN102240351A (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
| CN102247486B (en) | Bone health care marrow filling capsule | |
| CN104324319A (en) | Health-caring product promoting health of bone joint | |
| CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN108721531A (en) | Chinese medicine composition and preparation method thereof for treating gout | |
| CN103933277A (en) | Tibetan drug for treating gout disease | |
| CN107320539A (en) | Pharmaceutical composition for treating disc herniation | |
| CN103893436B (en) | A kind of externally applied drug for treating rheumatism | |
| CN107158188A (en) | A kind of Chinese medicine preparation for promoting fractures and bone injuries to heal | |
| CN102961612B (en) | Traditional Chinese medicine capsule for treating ankylosing spondylitis | |
| CN105381098A (en) | Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method | |
| CN105477067A (en) | Traditional Chinese medicine composition for treating dampness obstructing spleen-stomach type infantile jaundice | |
| CN104689176B (en) | A kind of Chinese medicine preparation for treating knee osteoarthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20171010 |